Vinegar-processed ginseng radix improves metabolic syndrome induced by a high fat diet in ICR mice

Archives of Pharmacal Research

Volumn 30, Issue 5, 2007, Pages 587-595

  Yun, Se Na ^a   Ko, Sung Kwon ^b   Lee, Kyung Hee ^c   Chung, Sung Hyun ^a  

^a Kyung Hee University   (South Korea)

^b Semyung University   (South Korea)

^c Yuyu Pharma Inc   (South Korea)

Author keywords

Ginsenoside; High fat diet; Metabolic syndrome; Vinegar processed ginseng radix

Indexed keywords

EID: 34249795447     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02977653     Document Type: Article

References (25)

1. Adult Treatment Panel III. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Final report. Circulation, 106, 3143-3421 (2002).
2. Athyros, V. G., Ganotakis, E. S., Elisaf, M., and Mikhailidis, D. P., The prevalence of the metabolic syndrome using the National Education Program and International Diabetes Federation definitions. Curr. Med. Res. Opin., 21, 1157-1159 (2005).
3. Attele, A. S., Zhou, Y. P., Xie, J. T., Wu, J. A., Zhang, L., Dey, L., Pugh, W., Rue, P. A., Polonsky, K. S., and Yuan, C. S., Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes, 51, 1851-1858 (2002).
4. Chen, M., Zhao, L., and Jia, W., Metabonomic study on the biochemical profiles of a hydrocortisone-induced animal model. J. Proteome Res., 4, 2391-2396 (2005).
5. Chevallier, A., Encyclopedia of herbal medicine. New York: DK Publishing (2000).
6. Chung, S. H., Choi, C. G., and Park, S. H., Comparisons between white ginseng radix and rootlet for antidiabetic activity and mechanism in KKAy mice. Arch. Pharm. Res., 24, 214-218 (2001).
7. Dyson, M. C., Alloosh, M., Vuchetich, J. P., Mokelke, E. A., and Sturek, M., Components of metabolic syndrome and coronary artery disease in female Ossabaw swine fed excess atherogenic diet. Comp Med., 56, 35-45 (2006).
8. Gazi, I., Liberopoulos, E., Mikhailidis, D. P., and Elisaf, M., Metabolic syndrome: clinical features leading to therapeutic strategies. Vas Dis. Prev., 1, 243-253 (2004).
9. Grundy, S., Brewer, B., Cleeman, J., Smith, S., and Lenfant, C., Definition of metabolic syndrome: report of the National Heart, Lung and Blood Institute/American Heart Association Conference on Scientific definition. Circulation, 109, 433-438 (2004).
10. Hwang, I. S., Ho, H., Hoffman, B. B., and Reaven, G. M., Fructose-induced insulin resistance and hypertension in rats. Hypertension, 10, 512-516 (1987).
11. Jeon, B. H., Kim, C. S., Kim, H. S., Park, J. B., Nam, K. Y., and Chang, S. J., Effect of Korean red ginseng on blood pressure and nitric oxide production. Acta. Pharmacol. Sin., 21, 1095-1100 (2000).
12. Kim, S. H. and Park, K. S., Effects of Panax ginseng extract on lipid metabolism in humans. Pharmacol. Res., 48, 511-513 (2003).
13. McFarlane, S. I., Banerji, M., and Sowers, J. R., Insulin resistance and cardiovascular disease. J. Clin. Endocrinol. Metab., 86, 716-718 (2001).
14. Oron-Herman, M., Rosenthal, T., Mirelman, D., Miron, T., Rabinkov, A., Wilchek, M., and Sela, B. A., The effects of S-allylmercaptocaptopril, the synthetic product of allicin and captopril, on cardiovascular risk factors associated with the metabolic syndrome. Atheroscelosis, 183, 238-243 (2005).
15. Reaeven, G. M., Role of insulin resistance in human disease. Diabetes, 37, 1595-1607 (1998).
16. Reaeven, G. M., The metabolic syndrome: requiescat in pace. Clin. Chem., 51, 931-938 (2005).
17. Sheu, W. H., Jeng, C. Y., Young, M. S., Le, W. J., and Chen, Y. T., Coronary artery disease risk predicted by insulin resistance, plasma lipids, and hypertension in people without diabetes, Am. J. Med. Sci., 319, 84-88 (2000).
18. Sievenpiper, J. L., Arnason, J. T., Leiter, L. A., and Vuksan, V., Variable effect s of American ginseng: a batch of American ginseng with a depressed ginsenoside profile does not affect postprandial glycemia. Eur. J. Clin. Nutr., 57, 243-248 (2003).
19. Sievenpiper, J. L., Arnason, J. T., Lawrence, A., Leiter, L. A., and Vuksan, V., Decreasing, null and increasing effects of eight popular types of ginseng on acute postprandial glycemic indices in healthy humans: the role of ginsenosides. J. Am. Coll. Nutr., 23, 248-258 (2004).
20. Sotaniemi, E. A., Haapakoski, E., and Rautio, A., Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care, 18, 1373-1375. (1995).
21. Sung, J., Han, K. H., Zo, J. H., Park, H. J., Kim, C.H. and Oh, B. H., Effects of red ginseng upon vascular endothelial function in patients with essential hypertension. Am. J. Chin. Med., 28, 205-216 (2000).
22. The IDF consensus worldwide definition of the metabolic syndrome, http://www.idf.org/webdata/doc/IDF-Metasyndrome_definition.pdf (2005).
23. Vuksan, V., Sievenpiper, J. L., Xu, Z., Wong, E. Y., Jenkins, A. L., and Beljan-Zdrakovic, U., Konjac-mannan and American ginseng: emerging alternative therapies for type 2 diabetes mellitus. J. Am. Coll. Nutr., 20, 370S-380S (2001).
24. Wang, B. X., Advances in study of pharmacology of ginseng. Acta. Pharmacol. Sin., 12, 477-486 (1965).
25. Yun, S. N., Moon, S. J., Ko, S. K., Im, B. O., and Chung, S. H., Wild ginseng prevents the onset of high-fat diet induced hyperglycemia and obesity in ICR mice. Arch. Pharm. Res., 27, 790-796 (2005).